Login to Your Account

U.K. court favors Fujifilm Kyowa Hakko Kirin in Humira patent litigation

By Haky Moon
Staff Writer

Monday, March 6, 2017

HONG KONG – In a final ruling, the U.K.'s High Court of Justice ruled in favor of Tokyo-based Fujifilm Kyowa Kirin Biologics Co. Ltd. in a patent revocation proceeding against Abbvie Inc., which has been fighting to protect its blockbuster Humira.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription